SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aurobindo Pharma informs about allotment of shares under ESOP

19 Jan 2016 Evaluate

Aurobindo Pharma has informed that the Nomination and Remuneration/Compensation Committee of the Company on January 19, 2016 has allotted 855,000 equity shares of Re 1 each under ESOP Scheme of the Company. Consequent to the allotment, the paid up share capital of the Company has increased from 583,964,550 Equity Shares of Re 1 each to 584,819,550 Equity Shares of Re 1 each.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1389.55 -6.95 (-0.50%)
30-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.20
Dr. Reddys Lab 1322.95
Cipla 1309.90
Zydus Lifesciences 891.65
Lupin 2303.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×